105 related articles for article (PubMed ID: 1963214)
1. Effects of the benzomorphan kappa-opiate, MR 2266 and its (+) enantiomer MR 2267, on thermonociceptive reactions in different strains of mice.
Bansinath M; Ramabadran K; Turndorf H; Puig MM
Neurosci Lett; 1990 Sep; 117(1-2):212-7. PubMed ID: 1963214
[TBL] [Abstract][Full Text] [Related]
2. Kappa-opioid receptor-mediated thermonociceptive mechanisms in streptozotocin diabetes.
Bansinath M; Ramabadran K; Turndorf H; Puig MM
Physiol Behav; 1991 Apr; 49(4):729-33. PubMed ID: 1652774
[TBL] [Abstract][Full Text] [Related]
3. Strain differences in the hyperalgesic effect of a novel kappa receptor agonist, U-50488H in mice.
Ramabadran K
Eur J Pharmacol; 1984 Mar; 98(3-4):425-7. PubMed ID: 6327334
[TBL] [Abstract][Full Text] [Related]
4. Effects of bremazocine on locomotor activity in DBA/2 and C57BL/6 mice.
Castellano C; Pavone F
Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):45-52. PubMed ID: 4096608
[TBL] [Abstract][Full Text] [Related]
5. Stereospecific effects of a kappa-opiate antagonist on the actions of morphine in morphine-tolerant rats.
Bhargava HN; Kremer EK; Gibbons MO; Philips BJ; Driver JW; Chou M
Eur J Pharmacol; 1989 Dec; 173(2-3):159-64. PubMed ID: 2560431
[TBL] [Abstract][Full Text] [Related]
6. Stereospecific inhibition of oxotremorine-induced antinociception by (+)-isomers of opioid antagonists: comparison with opioid receptor agonists.
Ben-Sreti MM; Sewell RD
J Pharm Pharmacol; 1982 Aug; 34(8):501-5. PubMed ID: 6126560
[TBL] [Abstract][Full Text] [Related]
7. Kappa-opiate agonist-induced inhibition of gastrointestinal transit in different strains of mice.
Bansinath M; Ramabadran K; Turndorf H; Puig MM
Pharmacology; 1991; 42(2):97-102. PubMed ID: 1648236
[TBL] [Abstract][Full Text] [Related]
8. Some observations on the effects of enantiomers of two benzomorphan narcotic antagonists and atropine on analgesia, tremor and hypothermia produced by oxotremorine.
Ben-Sreti MM; Sewell RD; Upton N
Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):219-27. PubMed ID: 7103612
[TBL] [Abstract][Full Text] [Related]
9. Opioid receptor selectivity of heroin given intracerebroventricularly differs in six strains of inbred mice.
Rady JJ; Elmer GI; Fujimoto JM
J Pharmacol Exp Ther; 1999 Feb; 288(2):438-45. PubMed ID: 9918543
[TBL] [Abstract][Full Text] [Related]
10. Effects of naloxone and Mr 2266 on thermonociceptive reactions in diabetic mice.
Ramabadran K; Bansinath M; Turndorf H; Puig MM
NIDA Res Monogr; 1989; 95():528-9. PubMed ID: 2561849
[No Abstract] [Full Text] [Related]
11. Stereospecific opiate receptors in the actions of thyrotropin releasing hormone and morphine on gastrointestinal transit.
Bhargava HN; Pillai NP
Life Sci; 1985 Jan; 36(1):83-8. PubMed ID: 2981381
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological studies with a nonpeptidic, delta-opioid (-)-(1R,5R,9R)-5,9-dimethyl-2'-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((-)-NIH 11082).
Aceto MD; May EL; Harris LS; Bowman ER; Cook CD
Eur J Pharmacol; 2007 Jul; 566(1-3):88-93. PubMed ID: 17434480
[TBL] [Abstract][Full Text] [Related]
13. Stereospecific antiarrhythmic effect of opioid receptor antagonists in myocardial ischaemia.
Parratt JR; Sitsapesan R
Br J Pharmacol; 1986 Apr; 87(4):621-2. PubMed ID: 3011165
[TBL] [Abstract][Full Text] [Related]
14. Genotype-dependent behavioral sensitivity to mu vs. kappa opiate agonists. II. Antinociceptive tolerance and physical dependence.
Gwynn GJ; Domino EF
J Pharmacol Exp Ther; 1984 Nov; 231(2):312-6. PubMed ID: 6092614
[TBL] [Abstract][Full Text] [Related]
15. Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man.
Pfeiffer A; Knepel W; Braun S; Meyer HD; Lohmann H; Brantl V
Horm Metab Res; 1986 Dec; 18(12):842-8. PubMed ID: 3028922
[TBL] [Abstract][Full Text] [Related]
16. Antagonistic effect of MR2266 and MR2267 on morphine or nalbuphine analgesia at the spinal levels in rats.
Kmieciak-Kołada K; Spiewak Z; Urbanowicz A; Pawłowski J; Herman ZS
Pol J Pharmacol; 1995; 47(6):509-18. PubMed ID: 8868373
[TBL] [Abstract][Full Text] [Related]
17. Opioid kappa receptors correlate with the development of conditioned suppression of motility in mice.
Nabeshima T; Kamei H; Kameyama T
Eur J Pharmacol; 1988 Jul; 152(1-2):129-33. PubMed ID: 2850197
[TBL] [Abstract][Full Text] [Related]
18. Central kappa- and mu-opiate receptors mediate ACTH-release in rats.
Pfeiffer A; Herz A; Loriaux DL; Pfeiffer DG
Endocrinology; 1985 Jun; 116(6):2688-90. PubMed ID: 2986960
[TBL] [Abstract][Full Text] [Related]
19. Stereospecific inhibition of gastrointestinal transit by kappa opioid agonists in mice.
Ramabadran K; Bansinath M; Turndorf H; Puig MM
Eur J Pharmacol; 1988 Oct; 155(3):329-31. PubMed ID: 2853069
[TBL] [Abstract][Full Text] [Related]
20. Genetic influences in opioid analgesic sensitivity in mice.
Pick CG; Cheng J; Paul D; Pasternak GW
Brain Res; 1991 Dec; 566(1-2):295-8. PubMed ID: 1667610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
